drugset / Trial / NCT03509220

Safety and Efficacy of PBK-1701TC for Bowel Cleansing Before Colonoscopy

NCT03509220 ↗

Phase 3 Completed 235 enrolled Pharmbio Korea Co., Ltd.
RandomizedParallel-groupSingle-blindDiagnostic

Summary

This study evaluates the efficacy, safety and tolerability of PBK-1701TC for bowel cleansing before colonoscopy. Half the participants will receive PBK-1701TC and while the other will receive standard oral preparation.

Timeline

Start
2018-04-11
Primary completion
2018-10-31
Completion
2018-10-31

Drugs

EvaluationDrugModalityDoseRoute
Subject PBK-1701TC Unknown — —

Indications